Medicines and therapies during COVID-19 pandemic

January 14, 2022 | 5:05pm
+ Follow Story
Medicines and therapies during COVID-19 pandemic
January 14, 2022

Pharmaceutical company Unilab addresses rumors that it is withholding stocks and increasing prices of flu, fever and cough medicines, which are in demand and short of supply in drug stores around the country as COVID-19 infections reach record levels.

In a statement, Unilab calls the situation "temporary" denies the rumors that Biogesic, Bioflu, Neozep, Solmux and Decolgen are being kept and sold for higher prices.

"The temporary out of stock situation in certain drugstores is due to the extraordinary high demand for products for fever, cough, colds and flu in certain areas of the country," it says.

"We continue to manufacture and in fact, increased the manufacturing volume of these products to serve the extraordinary demand."

A short thread on medicines, therapeutic alternatives and other drugs in the Philippines during the COVID-19 pandemic in 2022.

  • Latest
  • Trending
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

or sign in with